As a pharmaceutical company, Novo Nordisk faces a number of complex
bioethical issues which we take very seriously. Novo Nordisk bioethics
is governed in the top of our organisation by R&D Management with
Executive Management representation.
We address bioethical issues across the company via integration in
standard procedures, processes and decision-making and we have a
virtual cross-functional team that drives and proactively addresses
arising bioethical dilemmas.
One of the ways Novo Nordisk is committed to sustainability in
practice is to have a dedicated and systematic approach to drive and
proactively address emerging bioethical dilemmas related to research
and development. Internal, a network of researchers and managers
prepares and suggests new initiatives, develops and implements new
positions and guidelines, and supervises the company's handling of
evolving bioethical issues worldwide.